IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 114 filers reported holding IRADIMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 20,483 | $908,831 | 0.00% |
| GOLDMAN SACHS GROUP INC | 56,076 | $2,488,092 | 0.00% |
| MORGAN STANLEY | 53,407 | $2,369,692 | 0.00% |
| COMERICA BANK | 64 | $2,840 | 0.00% |
| Farther Finance Advisors, LLC | 24 | $1,065 | 0.00% |
| Invesco Ltd. | 6,921 | $307,084 | 0.00% |
| JPMORGAN CHASE & CO | 19,814 | $879,147 | 0.00% |
| AMALGAMATED BANK | 1,076 | $48 | 0.00% |
| Covestor Ltd | 8 | $0 | 0.00% |
| CWM, LLC | 120 | $5 | 0.00% |
| Citadel Advisors | 17,531 | $777,851 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13,118 | $582,046 | 0.00% |
| Tower Research Capital LLC (TRC) | 295 | $13,089 | 0.00% |
| Qube Research & Technologies Ltd | 2,765 | $122,683 | 0.00% |
External links
This page lists IRADIMED CORP's shareholders in Q3 2023. To view IRADIMED CORP's shareholder history, click here.